D&D Pharmatech Raises $51M in Series C Financing to Advance Potential Disease-Modifying Treatments for Neurodegenerative, Fibrotic, and Metabolic Diseases
Proceeds to Support Advancement of Phase 2 Clinical Trials Financing Led by Praxis Capital GYEONGGI-DO, Korea & GAITHERSBURG, Md.--(BUSINESS WIRE)--D&D...

SBI Research Outlines LTCG Tax Headroom as Air Suvidha Rule Mandated for All Arrivals
Sony kicks off 2026 PlayStation Store Black Friday sale early with up to 75% off games
Democrats Sweep US Midterm Elections, Winning Senate and House as Trump Faces Lame-Duck Presidency
Union Cabinet Approves Two-Year Extension for Agniveer Service Tenure
Kerala Lottery DhanaLekshmi DL-76 results declared for November 4 draw 


















